Eli Lilly (LLY)

• Market cap: $867B
• 1 day: 3.29%
• 5 days: 11.75%
• 1 month: 14.78%
• 3 months: 51.1%
• 6 months: 24.67%
• Year to date: 24.45%
• 1 year: 21.43%
• 5 years: 580.33%
• 10 years: 1,120.16%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000